This website uses cookies to give you the best user experience. If you continue
without changing your settings we'll assume you are happy to receive all RSC cookies.
You can change your cookie settings by navigating to our Privacy and Cookies page and following the instructions. These instructions
are also obtainable from the privacy link at the bottom of any RSC page.
Synthetic indirubin derivatives can selectively inhibit cyclin-dependent kinases, stalling cancer growth and proliferation. Peter Langer and co-worker...
MedChemComm themed issue: Chemical Biology for Target Identification and Validation Guest Editors: Nathanael Gray (Harvard University, USA) and Lyn Jo...
The RSC are delighted to be able to provide £400 bursaries for ten UK-based PhD student and early career researcher members to participate in the 44 t...